Clinical Guidelines
Feature

Targeted NGS Streamlines Myeloproliferative Neoplasm Diagnostics

Kritika Krishnamurthy shares real-world experience on advanced MPN genomic profiling

  • March 18, 2026

  • 9 min

Share

  • 1

    NGS enhances molecular profiling of MPNs.

  • 2

    Dr. Krishnamurthy emphasizes a combined approach.

  • 3

    Sequential PCR testing may miss co-mutations.

  • 4

    NCCN guidelines advocate for NGS in diagnostics.

  • 5

    Case studies illustrate the advantages of NGS.

  • 6

    Confirming low-level variants is crucial.

  • 7

    Integrated testing improves diagnosis and prognosis.

Original Source(s)

Targeted NGS Streamlines Myeloproliferative Neoplasm Diagnostics

  • March 18, 2026

Related Content

Romiplostim May Improve Chemotherapy-Induced Thrombocytopenia in Patients With GI Cancers

Romiplostim was beneficial in treating chemotherapy-induced thrombocytopenia, according to findings from the global phase III RECITE trial published in The New England Journal of Medicine.  

Register Today for Roswell Park’s Upstate New York Hematology & Hematologic Oncology Conference

Register for the Upstate New York Hematology & Hematologic Oncology Conference: A Review of the 67th ASH Annual meeting, taking place on April 25-26 in Buffalo, NY.

  • by

  • March 13, 2026

  • 1 min
Enhancing Immune Thrombocytopenia Education and Support: Insights From a Learning Exchange Program